Chinese biotech was big at JPM. Attendees were enthusiastic — and wary

Chinese biotech was big at JPM. Attendees were enthusiastic — and wary

China was big at JPM

The latest sign of the rise of China's biopharma sector? Chinese companies had a noticeably more visible presence at JPM. In San Francisco, that's meant greater availability for investor meetings and lots of events, often competing with one another.

And what say the U.S. executives and investors who spent the week soaking up the China biotech pitch? They're optimistic — but also wary of a sector that's had to contend with some scandal and disappointment, STAT's Rebecca Robbins reports.

Read more.